Few articles have additionally recommended the consideration of rapid sequence induction, stating that there should be a low threshold for this method of securing the airway, especially in the setting of uncertainty regarding gastric contents (Joshi 2024
Nine elastic mesh pockets let you organize exactly how your brain works
Ipamorelin triggers short, physiologic GH pulses that align with your circadian rhythm
ABSTRACT: Glucagon-like peptide-1 (GLP-1) agonists are a class of medications indicated for type 2 diabetes and obesity that may play a role in the management of cutaneous disease, in part due to their anti-inflammatory effects
Beyond T2DM, the Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes trial is assessing whether GLP-1 RAs can meaningfully reduce MACE, HF hospitalizations, and other cardiovascular endpoints in patients with type 1 diabetes, a population generally underrepresented in cardiovascular prevention studies [66]
Document when side effects occur and their severity